News

The Moratuwa facility will produce 2.5 billion Panadol brand of paracetamol tablets, annually, according to the Ministry of Industry and Commerce, reports news360.lk. Industry and Commerce minister Rishard

The transaction is expected to close in the second quarter, subject to certain closing conditions including regulatory approvals, and is expected to be immediately accretive. The acquired assets’

Through the investment, Mylan is expected to add more than 500 new positions to its Ireland-based workforce by 2016. The company’s investment will include funding for expanded research

The company now confirms that the $15m milestone associated with its licensing and development agreement with Endo Pharmaceuticals for BEMA Buprenorphine is payable. With this the total milestone

Discovered and developed by Sunovion Pharmaceuticals, Lunesta is a non-benzodiazepine type GABAA agonist (non-benzodiazepine sedative hypnotic). In a Phase II/III study (Study 126) conducted in Japan, patients treated

B cell ELISpot enables the activity of antibody-secreting memory B cells to be characterized at a cellular level. The characterization gives a detailed reading of immune responses in

The patent contains pharmaceutical composition claims covering NewLink’s HyperAcute products for the treatment of cancer. NewLink holds exclusive rights to the allowed application as well as to previously

IB1001 is an intravenous recombinant factor IX (rFIX) protein, and has completed pivotal Phase 3 clinical studies that support the filling of the BLA. Inspiration will receive a

LCIG is administered via a procedurally-implanted tube connected to a portable pump which delivers the medication directly into the small intestine, providing a continuous delivery of medication during